Conner, J <br/><br/>
A strategy for systemic delivery of the oncolytic herpes virus HSV1716: redirected tropism by antibody-binding sites incorporated on the virion surface as a glycoprotein D fusion protein.  [electronic resource] 

 -  Gene therapy  Dec 2008 
 - 1579-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5462 
<br/><br/><label>Standard No.: </label>10.1038/gt.2008.121  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ADP-ribosyl Cyclase 1--immunology<br/>Animals<br/>Binding Sites, Antibody--genetics<br/>CD55 Antigens--immunology<br/>CHO Cells<br/>Cricetinae<br/>Cricetulus<br/>ErbB Receptors--immunology<br/>Fluorescent Antibody Technique<br/>Genetic Therapy--methods<br/>Glycoproteins--genetics<br/>Humans<br/>Immunoglobulin Variable Region--genetics<br/>Injections, Intraperitoneal<br/>Mice<br/>Mice, Nude<br/>Microscopy, Fluorescence<br/>Neoplasms--immunology<br/>Oncolytic Virotherapy--methods<br/>Oncolytic Viruses--genetics<br/>Recombinant Fusion Proteins--administration & dosage<br/>Simplexvirus--genetics